Cytek Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTKB and other ETFs, options, and stocks.About CTKB
Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, Cytek Aurora, Cytek Northern Lights, and Cytek NL-CLC.
CEOWen Bin Jiang
CEOWen Bin Jiang
Employees648
Employees648
HeadquartersFremont, California
HeadquartersFremont, California
Founded1992
Founded1992
Employees648
Employees648
CTKB Key Statistics
Market cap691.11M
Market cap691.11M
Price-Earnings ratio-53.41
Price-Earnings ratio-53.41
Dividend yield—
Dividend yield—
Average volume921.86K
Average volume921.86K
High today$5.73
High today$5.73
Low today$5.34
Low today$5.34
Open price$5.65
Open price$5.65
Volume670.69K
Volume670.69K
52 Week high$6.18
52 Week high$6.18
52 Week low$2.37
52 Week low$2.37
Stock Snapshot
The current Cytek Biosciences(CTKB) stock price is $5.34, with a market capitalization of 691.11M. The stock trades at a price-to-earnings (P/E) ratio of -53.41.
On 2026-01-19, Cytek Biosciences(CTKB) stock moved within a range of $5.34 to $5.73. With shares now at $5.34, the stock is trading 0.0% above its intraday low and -6.8% below the session's peak.
Trading volume for Cytek Biosciences(CTKB) stock has reached 670.69K, versus its average volume of 921.86K.
The stock's 52-week range extends from a low of $2.37 to a high of $6.18.
The stock's 52-week range extends from a low of $2.37 to a high of $6.18.
People also own
Based on the portfolios of people who own CTKB. This list is generated using Robinhood data, and it’s not a recommendation.